Trial Profile
A Single-centre, Randomised, Double-blind, Single Dose, Cross-over Trial Investigating Safety and Pharmacokinetics of NNC 0128-0000-2011 Compared to NNC 0128-0000-2021, Following Intravenous Administration in Healthy Male Subjects
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 16 Oct 2014
Price :
$35
*
At a glance
- Drugs NN 7128 (Primary)
- Indications Haemophilia
- Focus Adverse reactions
- Sponsors Novo Nordisk
- 13 May 2014 New trial record